Inicio/Acciones/TWST

TWST

USD

Twist Bioscience Corporation Common Stock

$30.060-0.970 (-3.126%)

Precio en Tiempo Real

Healthcare

Diagnostics & Research

Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado

Fundamentos de la Empresa

Estadísticas de Negociación

Métricas de Mercado

Apertura

$31.030

Máximo

$31.390

Mínimo

$29.715

Volumen

1.91M

Fundamentos de la Empresa

Capitalización de Mercado

1.8B

Industria

Diagnostics & Research

País

United States

Estadísticas de Negociación

Volumen Promedio

1.74M

Bolsa

NMS

Moneda

USD

Rango de 52 Semanas

Mínimo $24.07Actual $30.060Máximo $55.33

Noticias Relacionadas

4 nov 2025 · 13:04

Analyst Upgrades

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

Stephens & Co. analyst Steven Etoch initiates coverage on Twist Bioscience with a Overweight rating and announces Price Target of $41.

Stephens & Co. Initiates Coverage On Twist Bioscience with Overweight Rating, Announces Price Target of $41

4 nov 2025 · 13:00

BusinessWire

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

Twist Bioscience Corporation (NASDAQ:TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist, will

Twist Bioscience to Present at 7th Annual Wolfe Research Healthcare Conference

3 nov 2025 · 13:00

BusinessWire

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ:TWST) ("Twist" or the "Company"), a mid-cap growth and value biotech company, today announced that it has granted a total of